Cargando…
Impact of COVID-19 on diagnosis of primary pulmonary coccidioidomycosis
The COVID-19 pandemic has disrupted medical care worldwide and caused delays in care for many illnesses and procedures unrelated to COVID-19; however, less clear is how it may have affected diagnosis of conditions that present with similar symptoms, such as primary pulmonary coccidioidomycosis (PPC)...
Autores principales: | Ashcherkin, Nikita, Gupta, Simran, Huff, Daniel A., Vikram, Holenarasipur R, Ampel, Neil M., Fischer, Karen M., Blair, Janis E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9439624/ https://www.ncbi.nlm.nih.gov/pubmed/36107584 http://dx.doi.org/10.1097/MD.0000000000030361 |
Ejemplares similares
-
Coccidioidomycosis in Patients Treated With Ruxolitinib
por: Kusne, Yael, et al.
Publicado: (2020) -
Coccidioidomycosis and COVID-19 Infection. An Analysis from a Single Medical Center Within the Coccidioidal Endemic Area
por: Huff, Daniel, et al.
Publicado: (2022) -
The diagnosis of coccidioidomycosis
por: Ampel, Neil M
Publicado: (2010) -
Serologic Rebound after Stopping Azoles for Primary Pulmonary Coccidioidomycosis: A Case-Controlled Observational Study
por: Shah, Priyal J., et al.
Publicado: (2023) -
Characteristics of Patients with Mild to Moderate Primary Pulmonary Coccidioidomycosis
por: Blair, Janis E., et al.
Publicado: (2014)